35.20
-4.16
(-10.57%)
At close: 6:17:46 PM GMT+1
Research Analysis
Earnings Estimate
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | -- | -- | -- | -- |
Avg. Estimate | 0 | 0 | 0 | 0 |
Low Estimate | 0 | 0 | 0 | 0 |
High Estimate | 0 | 0 | 0 | 0 |
Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | 6 | 6 | 7 | 7 |
Avg. Estimate | 695.9M | 737.72M | 3.12B | 3.52B |
Low Estimate | 660.16M | 692.55M | 2.95B | 3.37B |
High Estimate | 723M | 762.6M | 3.24B | 3.69B |
Year Ago Sales | 746.57M | 684.64M | 2.89B | 3.12B |
Sales Growth (year/est) | -6.79% | 7.75% | 8.01% | 12.73% |
EPS Trend
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Current Estimate | 0 | 0 | 0 | 0 |
7 Days Ago | 0 | 0 | 0 | 0 |
30 Days Ago | 0 | 0 | 0 | 0 |
60 Days Ago | 0 | 0 | 0 | 0 |
90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | -- | -- | -- | -- |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
Current Qtr. | Next Qtr. | Current Year | Next Year | |
---|---|---|---|---|
0UB6.L | -- | -- | -- | -- |
S&P 500 | 6.68% | 6.74% | 9.91% | 14.34% |
Upgrades & Downgrades
Maintains | Morgan Stanley: Equal-Weight to Equal-Weight | 3/13/2025 |
Maintains | UBS: Neutral to Neutral | 2/3/2025 |
Maintains | Keefe, Bruyette & Woods: Market Perform to Market Perform | 1/31/2025 |
Maintains | Wells Fargo: Equal-Weight to Equal-Weight | 1/31/2025 |
Maintains | Morgan Stanley: Equal-Weight to Equal-Weight | 1/31/2025 |
Maintains | Goldman Sachs: Sell to Sell | 1/15/2025 |